Health systems, hospitals, provider organizations, physician groups, and government healthcare agencies all have a common goal: deliver efficient and effective care that leads to better health. But changing reimbursement requirements, demands for quality-of-care improvements, changing regulatory requirements, and tighter resources and budgets can challenge progress.
Leveraging the IQVIA CORE™ – our domain expertise, unparalleled data, advanced analytics, and transformative technology – you can unlock new opportunities to deliver efficient and effective care with confidence.
Drive performance improvements
We deliver fit-for-purpose solutions that capture the data and insights you need to make decisions on a local level, increase operational efficiencies, and drive better care at optimal costs. Around the globe, our suite of measurement, reporting, and management tools can help you with:
- Process optimization across hospital workflows to improve overall performance and patient experience
- Control systems that monitor treatment expenditures and reduce drug fraud, waste, misuse, and abuse
- Care pathway analytics for quick and clear data visualizations that identify unnecessary variations and opportunities for integrated care
- Industry benchmarking to compare financial and operational performance, and target areas for improvement
- Patient experience reporting for a comprehensive understanding of patient engagement, satisfaction, and outcomes
Global expertise | Local optimization
Our expertise isn’t bound by borders. We work with customers across geographies to navigate market and quality-of-care demands with locally optimized solutions, including locations:
Acute and complex patient populations. Meeting unmet needs.
Expansive data and information partnerships, advanced predictive analytics, and human data science work together to identify the unmet needs of high cost specialty care and rare disease patient populations.
Aggregated results from individual hospitals can generate a collective understanding of the broader disease experience in targeted populations, including: oncology, neuromuscular disease, cystic fibrosis, and hemophilia.
New treatment options become available to patients through networked, consortium driven analytics, and the opportunity to participate in innovative clinical research.